InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: None

Thursday, 05/09/2019 10:00:36 AM

Thursday, May 09, 2019 10:00:36 AM

Post# of 1140
Details (with redactions) of the agreement with Serum have been filed: https://www.sec.gov/Archives/edgar/data/1213809/000121380919000027/a101serumresearchandcommer.htm

Serum generates over $600MM in worldwide revenue, with GMP facilities across Europe.

Again Dyadic appears to have the partner foot the bill for the R&D and clinical trials, and pay out royalties if/when commercialized. Such a great business model. And they only signed away 12 specific compounds.. there are surely hundreds if not thousands they could have similar deals for.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News